Patent details
EP1431311 Title: Immunotherapy of B-cell malignancies using anti-CD22 and anti-CD20 antibodies in combination
Basic Information
- Publication number:
- EP1431311
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP040757759
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Immunotherapy of B-cell malignancies using anti-CD22 and anti-CD20 antibodies in combination
- French Title of Invention:
- Immunotherapie de tumeurs de cellules B avec une combinaison d'anticorps anti-CD22 et anti-CD20
- German Title of Invention:
- Immunotherapie von B-Zellen Krebs mit einer Kombination von Anti-CD22 und Anti-CD20 Antikörpern
- SPC Number:
Dates
- Filing date:
- 17/03/1998
- Grant date:
- 20/07/2016
- EP Publication Date:
- 20/07/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/06/2004
- EP B1 Publication Date:
- 20/07/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 17/03/2017
- Expiration date:
- 17/03/2018
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/03/1998
- Name:
- Immunomedics Inc.
- Address:
- 300 American Road, Morris Plains, NJ 07950, United States (US)
Inventor
- Name:
- Goldenberg David M.
- Address:
- United States (US)
Priority
- Priority Number:
- 41506 P
- Priority Date:
- 24/03/1997
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 16/28;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|